UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y
Number of items: 399.

A

Ah-See, MLW; Makris, A; Burcombe, RJ; Davies, C; Cladd, HJ; Padhani, AR; Harris, AL; (2003) Evaluation of plasma & serum vascular endothelial growth factor (VEGF) during neoadjuvant chemotherapy for primary breast cancer. British Journal of Cancer , 88 S44-S44.

Ah-See, MLW; Taylor, NJ; Makris, A; Burcombe, RJ; Stirling, JJ; Cladd, HJ; Leach, MO; (2003) Valuation of multi-functional dynamic contrast-enhanced MRI to predict response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 88 S41-S41.

Ahmedzai, S; Hoskin, PJ; (2003) Assessment and management of malignant disease. In: Muers, MF, (ed.) Oxford Textbook: Supportive Care in Respiratory Disease. Oxford University Press: Oxford.

Alsowmely, A; Grasso, A; Hodgson, H; Burroughs, A; Davidson, B; Quaglia, A; Dhillon, A; (2003) Life-table analysis of survival after liver transplantation for hepatocellular carcinoma: A single centre study. In: (pp. 64-).

Alvi, AJ; Clayton, H; Joshi, C; Enver, T; Ashworth, A; Vivanco, MD; Dale, TC; (2003) Functional and molecular characterisation of mammary side population cells (vol 5, pg R1, 2003). BREAST CANCER RESEARCH , 5 (1) 10.1186/bcr563.

Ameer-Beg, SM; Edme, N; Peter, M; Barber, PR; Ng, T; Vojnovic, B; (2003) Imaging protein-protein interactions by multiphoton FLIM. Proceedings of SPIE - The International Society for Optical Engineering , 5139 pp. 180-189.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, I; Linch, DC; (2003) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. BRIT J HAEMATOL , 120 (4) 685 - 690.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171. 10.1080/1024533031000107497.

Ann, F; (2003) Thalidomide: horror and redemption. Cancer Nursing Practice , 2 (25) pp. 10-12.

Ardeshna, K.M.; Smith, P.; Norton, A.; Hancock, B.W.; Hoskin, P.J.; MacLennan, K.A.; Marcus, R.E.; ... Linch, D.C.; + view all (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. The Lancet , 362 (9383) pp. 516-522. 10.1016/S0140-6736(03)14110-4.

Ardeshna, KM; Kakouros, N; Qian, WD; Powell, MG; Saini, N; D'Sa, S; Hoskin, PJ; ... Linch, DC; + view all (2003) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease in response to first line salvage chemotherapy regimens. In: BLOOD. (pp. 400A - 400A). AMER SOC HEMATOLOGY

Arkenau, HT; Bermann, A; Rettig, K; Strohmeyer, G; Porschen, R; (2003) 5-fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. ANNALS OF ONCOLOGY , 14 (3) pp. 395-399. 10.1093/annonc/mdg100.

Arkenau, HT; Kruse, F; Jend, HH; Porschen, R; (2003) Differential diagnosis of Morbus Crohns disease: Intussusception of the colon. Zeitschrift fur Gastroenterologie , 41 (7) pp. 663-666. 10.1055/s-2003-40549.

Arnett, TR; Massey, HM; Utting, JC; Orriss, IR; Flanagan, AM; (2003) Hypoxia is a major stimulator of osteoclast formation from human peripheral blood. In: (pp. pp. 345-346).

Assersohn, L; Salter, J; Powles, TJ; A'Hern, R; Makris, A; Gregory, RK; Chang, J; (2003) Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer. Breast Cancer Research and Treatment , 82 (2) pp. 113-123.

Attygalle, AD; Chuang, SS; Diss, TC; Hamoudi, RA; Munson, P; Du, MQ; Isaacson, PG; (2003) Nodal peripheral T-cell lymphomas: the role of CD10 in diagnosis. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 4A-4A). WILEY-BLACKWELL

B

BBC, NO; (2003) Blood test spots 'asbestos cancer'. UNSPECIFIED

BBC, NO; (2003) Scans help spot lung cancer early. UNSPECIFIED

BBC, NO; (2003) Thalidomide trials to fight cancer. UNSPECIFIED

BBC, NO; (2003) Warning to heed lung cancer signs. UNSPECIFIED

BBC, R4; (2003) Thalidomide Trial. UNSPECIFIED

Bain, BJ; Gupta, R; (2003) A-Z of haematology. [Book]. Wiley-Blackwell

Baker, RJ; Gerrard, G; Wickremasinghe, RG; Hoffbrand, AV; Mehta, AB; Ross, DD; Ganeshaguru, K; (2003) Expression of breast cancer resistance protein in malignant cells from patients with leukaemia. In: LEUKEMIA. (pp. 662 - 662). NATURE PUBLISHING GROUP

Barnes, EJ; Abdel-Rehim, MM; Goulis, Y; Abou Ragab, M; Davies, S; Dhillon, A; Davidson, B; ... Burroughs, A; + view all (2003) Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. American Journal of Transplantation , 3 (4) pp. 432-438.

Barrie, SE; Eno-Amooquaye, E; Hardcastle, A; Platt, G; Richards, J; Bedford, D; Workman, P; ... Garrett, MD; + view all (2003) High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. ANALYTICAL BIOCHEMISTRY , 320 (1) pp. 66-74. 10.1016/S0003-2697(03)00349-X.

Bates, AW; (2003) Autopsy on a case of roberts syndrome reported in 1672: The earliest description? AM J MED GENET A , 117A (1) 92 - 96. 10.1002/ajmg.a.10864.

Bates, AW; (2003) The sooterkin dissected: the theoretical basis of animal births to human mothers in early modern Europe. Vesalius , 9 pp. 6-14.

Bates, AW; Sebire, NJ; Williams, S; Ramsay, AD; (2003) Variable antigen expression in Hepatoblastomas. In: JOURNAL OF PATHOLOGY. (pp. 42A - 42A). JOHN WILEY & SONS LTD

Beck, S; (2003) Immunogenomics: towards a digital immune system. Novartis Found Symp , 254 pp. 223-230.

Benjamin, E; Isaacson, P; (2003) Lymphoproliferative disease of the female genital tract. In: Fox, H and Wells, M, (eds.) Obstetrical and Gynaecological Pathology. (pp. 935-962). Churchill Livingstone

Benjamin, R; Davidoff, AM; Ng, CYC; Pizzey, A; Yong, K; Nathwani, AC; (2003) Murine models of hematological malignancies that mimic the disease phenotype in humans. In: BLOOD. (pp. 888A - 888A). AMER SOC HEMATOLOGY

Bennett, CL; Colledge, L; Richards, HE; Reay, PA; Blackburn, CC; Aebischer, T; (2003) Uncompromised generation of a specific H-2DM-dependent peptide-MHC class II complex from exogenous antigen in Leishmania mexicana-infected dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 33 (12) pp. 3504-3513. 10.1002/eji.200323425.

Beresford, M; Glynne-Jones, R; Makris, A; Harrison, M; (2003) Lymph node staging following preoperative chemoradiation in rectal cancer. British Journal of Cancer , 88 S21-S21.

Birtle, AJ; Freeman, A; Masters, JRW; Payne, HA; Harland, SJ; (2003) Clinical Features of Patients Who Present with Metastatic Prostate Carcinoma and Serum Prostate-Specific Antigen (PSA) Levels < 10 ng/mL: The "PSA Negative" Patients. Cancer , 98 (11) pp. 2362-2367. 10.1002/cncr.11821.

Bogunia-Kubik, K; Natarajan, P; Brown, S; Wolley, J; Alcocer, M; Fallen, PR; Madrigal, JA; (2003) Cord blood serum affects T cells ability to produce and respond to IL-2. Cytokine , 22 (1-2) pp. 42-49.

Borthwick, NJ; Akbar, AA; Buckley, C; Pilling, D; Salmon, M; Jewell, AP; Yong, KL; (2003) Transendothelial migration confers a survival advantage to activated T lymphocytes: role of LFA-1/ICAM-1 interactions. CLIN EXP IMMUNOL , 134 (2) 246 - 252. 10.1046/j.1365-2249.2003.02298.x.

Boshoff, C; (2003) Kaposi virus scores cancer coup. NAT MED , 9 (3) 261 - 262. 10.1038/nm0303-261.

Boshoff, C; (2003) Kohn to Kaposi. NAT MED , 9 (3) 262 - 262. 10.1038/nm0303-262.

Bowen, DT; Frew, MEC; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; Langabeer, SE; ... Linch, DC; + view all (2003) RAS gene mutation in acute myeloid leukemia; Analysis of cases from the medical research council AML 10 and 12 clinical trials. In: BLOOD. (pp. 374A - 375A). AMER SOC HEMATOLOGY

Braithwaite, D; Sutton, S; Mackay, J; Stein, J; Hopkinson, I; Emery, J; (2003) UNSPECIFIED In: (Proceedings) 'Computer support for genetic risk assessment and advice about breast cancer susceptibility: a feasibility study of patient self-assessment in a family history clinic'. In AACR Frontiers in Cancer Prevention, Phoenix, Arizona, 26-30 October.

Brookman-Amissah, N; Price, RK; Foxon, R; Mackay, A; O'Hare, MJ; Stein, RC; (2003) The effects of estradiol and ICI 182,780 treatment of primary breast cancer cells on gene transcription and comparison to effects in established cell lines. In: (Proceedings) British Cancer Research Meeting 2003. (pp. S49-S49). NATURE PUBLISHING GROUP

Brooks, A; Clingan, P; Morris, D; (2003) Hepatic artery chemotherapy and colorectal liver metastases. Lancet , 361 (9370) 1742-. 10.1016/S0140-6736(03)13340-5.

Brown, SA; Yee, TT; Griffioen, A; Lee, CA; (2003) Comparative study of full-length and B-domain deleted factor VIII concentrates. HAEMOPHILIA , 9 (6) 745 - 745.

Burk, K; (2003) The Ageing Wine-Drinker. Prospect (10/2003) p. 50.

Burk, K; (2003) Anything But Chardonnay. Prospect (6/2003) p. 58.

Burk, K; (2003) Corks Versus Screwtops. Prospect (1/2003) p. 18.

Burk, KM; (2003) Anglo-American Relations before they were 'Special'. In: Capet, A and Sy-Wonyu, A, (eds.) The 'Special Relationship'. La 'relation spéciale' entre le Royaume Uni et les Etats Unis. (pp. 3-17). Publications de l'université de Rouen: Rouen.

C

Calvert, H; (2003) Developing drugs for cancer: Striking balance between clinical pragmatism and scientific allure. In: BRITISH JOURNAL OF CANCER. (pp. S7 - S7). NATURE PUBLISHING GROUP

Camilleri, ; Cohen, H; (2003) Venous thromboembolism and the -455F/A b-fibrinogen polymorphism. In: (Proceedings) International society of thrombosis and haemostasis.

Camilleri, RS; Mackie, IJ; Humphries, SE; Machin, SJ; Cohen, H; (2003) Lack of association of beta 2-glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications. BRIT J HAEMATOL , 120 (6) 1066 - 1072.

Carnell, D; Smith, R; Taylor, J; Stirling, J; Hoskin, P; Padhani, A; (2003) Evaluation of hypoxia within human prostate carcinoma using quantified bold MRI and pimonidazole immunohistochemical mapping. British Journal of Cancer , 88 S12-S12.

Carnell, DM; Daley, FM; Smith, RE; Hoskin, P; Murray, GI; Everett, SA; (2003) CYP1B1 protein expression in prostate carcinoma. British Journal of Cancer , 88 S34-S34.

Catherine, E; (2003) Thalidomide used in trials to cure cancer. Camden New Journal 25-.

Cecilioni, L; Stigliano, R; Leandro, G; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; ... Burroughs, A; + view all (2003) Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population. In: (pp. 452-).

Cecilioni, L; Stigliano, R; Leandro, G; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; ... Burroughs, A; + view all (2003) Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population. In: HEPATOLOGY. (pp. 379A - 379A). W B SAUNDERS CO

Chakraborty, R; Rees, G; Bourboulia, D; Cross, AM; Dixon, JR; D'Agostino, A; Musoke, R; ... Klenerman, P; + view all (2003) Viral coinfections among African children infected with human immunodeficiency virus type 1. CLIN INFECT DIS , 36 (7) 922 - 924.

Chelvatheebam, S; Langabeer, SE; Linch, DC; Hills, RK; Greenwell, P; (2003) Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia. LEUKEMIA RES , 27 (9) 869 - 870. 10.1016/S0145-2126(03)00016-X.

Chen, FE; Dodi, AI; Travers, PJ; Madrigal, AJ; (2003) Age dependent differentiation status of virus specific CTL - Immunological implications of age as a risk factor in SCT. BLOOD , 102 (11) 2582-.

Chicken, DW; Leel, AC; Pickard, CDO; Falzon, M; Bown, SG; Yu, RC; Scarisbrook, J; ... Keshtgar, MRS; + view all (2003) Optical biopsy - a novel perioperative diagnostic tool in surgical oncology. In: BRITISH JOURNAL OF SURGERY. (pp. 35 - 35). JOHN WILEY & SONS LTD

Chuah, C; Tipping, AJ; Goldman, JM; Melo, JV; (2003) Zoledronate is active against imatinib mesylate-resistant chronic myeloid leukemia cell lines and synergistic/additive when combined with imatinib mesylate. In: BLOOD. (pp. 19A - 19A). AMER SOC HEMATOLOGY

Ciocchetta, F; Dell'Anna, R; Demichelis, F; Dhillon, AP; Quaglia, A; Sboner, A; (2003) Combining supervised and unsupervised methods to support early diagnosis of hepatocellular carcinoma. In: Dojat, M and Keravnou, E and Barahona, P, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 239 - 243). SPRINGER-VERLAG BERLIN

Ciocchetta, F; Dell'Anna, R; Demichelis, F; Sboner, A; Dhillon, AP; Dhillon, A; Godfrey, A; (2003) Knowledge discovery in support of early diagnosis of hepatocelluar carcinoma. In: PROCEEDINGS OF THE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS 2003, VOLS 1-4. (pp. 177 - 181). IEEE

Clark, FJ; Piper, K; Gregg, R; Dunnion, D; Freeman, L; Mahendra, P; Craddock, C; ... Chakraverty, RK; + view all (2003) Characterisation of regulatory T-cells in patients with chronic graft-versus-host disease. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Hematology. (pp. 408B-408B). AMER SOC HEMATOLOGY

Clingen, PH; DeSilva, IU; Ghadessy, FJ; Thurston, DE; Hartley, JA; (2003) The role of nucleotide excision repair and homologous recombination in the sensitivity of mammalian cells to the minor groove crosslinking pyrrolo[2,1-c][1,4]benzodiazepine dimmer SJG-136(NSC694501). In: (pp. 2672-).

Coeytaux, E; Coulaud, D; Le Cam, E; Danos, O; Kichler, A; (2003) The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem , 278 (20) pp. 18110-18116. 10.1074/jbc.M300248200. Gold open access

Cohen, H; (2003) How to stimulate active participation in haemovigilance. In: (Proceedings) European haemovigilance network.

Cohen, H; (2003) SHOT - the future. [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Stainsby, D; (2003) The 2001/2002 annual SHOT Report (on behalf of the serious hazards of transfusion steering group).

Colombo, N; du Bois, A; Kristensen, G; Ledermann, J; Torri, V; (2003) ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit - Reply. LANCET , 362 (9392) p. 1334. 10.1016/S0140-6736(03)14604-1.

Conde, L; Mateos, A; Herrero, J; Dopazo, J; (2003) Improved class prediction in DNA microarray gene expression data by unsupervised reduction of the dimensionality followed by supervised learning with a perceptron. In: (Proceedings) 12th IEEE Workshop on Neural Networks for Signal Processing. (pp. pp. 245-253). KLUWER ACADEMIC PUBL

Corrie, P; Spanswick, VJ; Sehmbi, R; Jonson, A; Shaw, J; Dowen, S; Biswas, S; ... Hartley, JA; + view all (2003) Increased persistence of treosulfan-induced DNA interstrand crosslinks when combined with gemcitabine: Proof of principle within a phase I trial. In: (pp. 128-).

Corsini, E; Viviani, B; Zancanella, O; Lucchi, L; Visioli, F; Serrero, G; Bartesaghi, S; ... Marinovich, M; + view all (2003) Induction of adipose differentiation related protein and neutral lipid droplet accumulation in keratinocytes by skin irritants. J INVEST DERMATOL , 121 (2) 337 - 344.

Corsini, E; Zancanella, O; Lucchi, L; Visioli, E; Viviani, B; Bartesaghi, S; Marinovich, M; (2003) Induction of adipose differentiation related protein and neutral lipid droplets accumulation in keratinocytes by skin irritants. In: TOXICOLOGICAL SCIENCES. (pp. 382 - 382). OXFORD UNIV PRESS

Cox, ST; McWhinnie, AJ; Robinson, J; Marsh, SGE; Parham, P; Madrigal, JA; Little, AM; (2003) Cloning and sequencing full-length HLA-B and -C genes. TISSUE ANTIGENS , 61 (1) pp. 20-48. 10.1034/j.1399-0039.2003.610103.x.

Cox, TM; Aerts, JM; Andria, G; Beck, M; Belmatoug, N; Bembi, B; Chertkoff, R; ... Zimran, AACTTEWGOGD; + view all (2003) The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. PMID: 14605497 , 26 (6) pp. 513-526.

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Selden, C; Sim, R; North, J; ... Dhillon, AP; + view all (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: JOURNAL OF PATHOLOGY. (pp. 2A - 2A). JOHN WILEY & SONS LTD

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; North, J; ... Dhillon, AP; + view all (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: (pp. 109-).

Crowley, J; Hagan, R; Clancy, D; Rooney, G; Dunne, C; Lawlor, E; Hayden, P; ... Madrigal, JA; + view all (2003) Two sets of HLA class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Antigens , 61 pp. 487-491.

Crowley, J; Hagan, R; Clancy, D; Rooney, G; Dunne, C; Lawlor, E; Hayden, P; ... Madrigal, JA; + view all (2003) Two sets of HLA class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Antigens , 61 pp. 487-491.

D

Daly, ME; Makris, A; Reed, M; Lewis, CE; (2003) Hemostatic regulators of tumor angiogenesis: A source of antiangiogenic agents for cancer treatment? Journal of the National Cancer Institute , 95 (22) pp. 1660-1673.

Damien, E; Hing, K; Saeed, S; Revell, PA; (2003) A preliminary study on the enhancement of the osteointegration of a novel synthetic hydroxyapatite scaffold in vivo. Journal of Biomedical Materials Research Part A , 66A (2) pp. 241-246.

Dangoor, A; Ranson, M; Lee, SM; Beech, J; Sherlock, DJ; Wilkinson, PM; Valle, JW; (2003) Treatment of inoperable hepatocellular carcinoma (HCC) with pegylated liposomal doxorubicin (Caelyx). In: (Proceedings) 2003 ASCO Annual Meeting/39th Annual Meeting, Chicago, Illinois.. (pp. 361-). Proceedings of the American Society of Clinical Oncology

David, F; (2003) Birth defects drug is poised for comeback. Financial Times

Davidoff, AM; Ng, CY; Zhou, J; Spence, Y; Nathwani, AC; (2003) Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood , 102 (2) pp. 480-488. 10.1182/blood-2002-09-2889. Green open access
file

Davies, JK; Joh, MB; Prentice, HG; Lowdell, MW; (2003) Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3. In:

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. BLOOD , 102 (11) 3542-.

Davies, JK; Marden, C; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. In: BLOOD. (pp. 951A - 951A). AMER SOC HEMATOLOGY

Davies, JK; Marden, CM; Sviland, L; Lowdell, MW; (2003) Alloreactive NK cells do not mediate GvHD in the human skin explant model - implications for development of an allogenic NK cell recipient conditioning approach. In: (pp. 951-).

Davis, AM; Dische, S; Gerber, L; Saunders, M; Leung, SF; O'Sullivan, B; (2003) Measuring postirradiation subcutaneous soft-tissue fibrosis: State-of-the-art and future directions. Seminars in Radiation Oncology , 13 (3) pp. 203-213.

DeCanha, S; Hoskin, PJ; (2003) Current thinking of the role of radiotherapy in metastatic disease. In: Miles, A, (ed.) Key Advances in the effective Management of Breast Cancer. Royal College of Physicians: London.

Dearling, JL; Flynn, AA; Sutcliffe-Goulden, J; Boden, R; Boxer, GM; Begent, RHJ; Pedley, RB; (2003) Deoxyglucose microdistribution in major pathophysiological tumour compartments. In: (pp. 24-).

Dehout, F; Schwarting, A; Beck, M; Mehta, A; Ricci, R; Widmer, UFOSI; (2003) Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatrica - Supplement , 92 (443) pp. 14-15.

Dhar, A; Johnson, KS; Novelli, MR; Bown, SG; Lovat, LB; Bloom, SL; (2003) Optical biopsy of colonic lesions: Comparison of elastic scattering spectroscopy with histology. In: (pp. A1-).

Dische, S; Saunders, MI; (2003) Complexity and simplicity in the measurement and recording of the adverse effects of cancer treatment. Radiotherapy And Oncology , 66 (3) pp. 249-251.

Diss, TC; (2003) The Polymerase Chain Reaction. In: Crocker, J and Murray, PG, (eds.) Molecular Biology in Cellular Pathology. (pp. 193-212). John Wiley and Sons: West Sussex.

Donev, R; Horton, R; Beck, S; Doneva, T; Vatcheva, R; Bowen, WR; Sheer, D; (2003) Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex. J BIOL CHEM , 278 (7) 5214 - 5226. 10.1074/jbc.M206621200. Gold open access

Douar, AM; Poulard, K; Danos, O; (2003) Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid. Virology , 309 (2) pp. 203-208.

Dudderidge, TJ; (2003) Urinary markers in bladder cancer. BJU INT , 92 (7) 823 - 824.

Dudderidge, TJ; Arya, M; Young, J; Davies, AJW; (2003) Stop those anti-platelet drugs before surgery! BJU Int , 92 (6) pp. 654-655.

Dudderidge, TJ; Arya, M; Young, J; Davies, AJW; (2003) Untitled. BJU INT , 92 (6) 654 - 655.

Duke, VM; Gandini, D; Sherrington, PD; Lin, K; Heelan, B; Amlot, P; Mehta, AB; ... Foroni, L; + view all (2003) V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica , 88 (11) 1259 - 1271. Green open access
file

de Groot, NG; Garcia, CA; Doxiadis, GGM; Marsh, SGE; Bontrop, RE; (2003) The "non-classical" MIC gene in chimpanzees shows reduced exon/intron variation as compared to humans. Genes and Immunity , 4 6-.

E

Eccersley, AJ; Wilson, EM; Makris, A; Novell, JR; (2003) Referral guidelines for colorectal cancer - do they work? Annals of the Royal College of Surgeons of England , 85 (2) pp. 107-110.

Eisman, S; Mehta, A; Orteu, CH; (2003) Case 3. Fabry disease. Clinical and Experimental Dermatology , 28 (5) pp. 569-570.

Enver, T; (2003) Blueprints for blood. BLOOD , 101 (2) p. 381. 10.1182/blood-2002-11-3426.

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; Hoffmann, R; ... Sarno, S; + view all (2003) Transcriptional programming and reprogramming in haematopoietic stem cells. In: (Proceedings) 13th Conference on Hemoglobin Switching. (pp. pp. 139-140). ACADEMIC PRESS INC ELSEVIER SCIENCE

F

Fallen, PR; Duarte, RF; McGreavey, L; Potter, M; Ethell, M; Prentice, HG; Madrigal, JA; (2003) Identification of non-naive CD4(+) CD45RA(+) T cell subsets in adult allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPLANTATION , 32 (6) pp. 609-616.

Fallen, PR; McGreavey, L; Madrigal, JA; Potter, M; Ethell, M; Prentice, HG; Guimaraes, A; (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPLANTATION , 32 (10) pp. 1001-1014.

Field, N; Low, W; Daniels, M; Howell, S; Daviet, L; Boshoff, C; Collins, M; (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J CELL SCI , 116 (18) 3721 - 3728. 10.1242/jcs.00691.

Fields, PA; Cohen, H; Patterson, KG; (2003) Splenunculectomy in autoimmune thrombocytopenic purpura. Br J Haematol , 123 (3) 377-.

Flanagan, AM; Massey, HM; (2003) Generating human osteoclasts in vitro from bone marrow and peripheral blood. In: UNSPECIFIED (pp. 113-128).

Flanagan, J; Healey, S; Young, J; Whitehall, V; Chenevix-Trench, G; (2003) Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumour suppressor gene in colorectal cancer. International Journal of Cancer , 106 (4) pp. 505-509.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Boden, RABRHJ; (2003) The heterogeneity of antibody distribution in kidney and its influence on dosimetry. Radiation Research , 159 pp. 182-189.

Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; Boden, R; (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. RADIAT RES , 159 (2) 182 - 189.

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehra, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye. In: BLOOD. (pp. 347B - 348B). AMER SOC HEMATOLOGY

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehta, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukemia patients using a highly fluorescent Alexa Fluor dye. In: (pp. 5116-).

Foroni, L; Sorour, AF; Sinclair, PB; Duke, VM; (2003) Loss of heterozygosity (LOH) and microsatellite instability (MSI) of chromosome 6q16-21 identifies a prognostically poor group of childhood and adult T cell precursor acute lymphoblastic leukaemia (ALL) patients. BLOOD , 102 (11) 2236-.

Forshew, T; Johnson, CA; Willis, C; Moore, AT; Maher, ER; (2003) Mapping of an autosomal recessive congenital cataract locus to chromosome 9q. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 489 - 489). UNIV CHICAGO PRESS

Forshew, T; Johnson, CA; Willis, C; Moore, AT; Maher, ER; (2003) Mapping of an autosomal recessive congenital cataract locus to chromosome 9q. In: JOURNAL OF MEDICAL GENETICS. (pp. S86 - S86). B M J PUBLISHING GROUP

Francis, DL; Freeman, A; Visvikis, D; Costa, DC; Luthra, SK; Novelli, M; Taylor, I; (2003) Can PET quantify cellular proliferation in colorectal cancer? A comparative study using MIB-1 and a new PET tracer 18FLT. In: (pp. pp. 29-30).

Freeman, MAR; MacInnes, T; Revell, PA; (2003) The histology of "reactive lines"' in well-fixed components. The Journal of Arthroplasty , 18 (2) pp. 224-226.

Friedmann, BJ; Caplin, M; Hartley, JA; Hochhauser, D; (2003) UNSPECIFIED In: (Proceedings) Modulation of the activity of chemotherapeutic agents by the epidermal growth factor inhibitor gefitinib ('Iressa', ZD1839). Clinical Cancer Research

Friedmann, BJ; Caplin, M; Hartley, JA; Hochhauser, D; (2003) Modulation of the activity of chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in human cancer cell lines. In: CLINICAL CANCER RESEARCH. (pp. 6094S - 6094S). AMER ASSOC CANCER RESEARCH

G

Gaffan, J; Holden, L; Newlands, ES; Short, D; Fuller, S; Begent, RHJ; Rustin, GJS; (2003) Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. BRIT J CANCER , 89 (10) 1849 - 1854. 10.1038/sj.bjc.6601383.

Gale, RE; (2003) Pathogenic markers in essential thrombocythemia. Curr Hematol Rep , 2 (3) pp. 242-247.

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2003) Ansamycins synergize with conventional drugs in apoptotic killing of B-chronic lymphocytic leukaemia cells. In:

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2003) Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. In: BLOOD. (pp. 349B - 349B). AMER SOC HEMATOLOGY

Garcia, CA; Robinson, J; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2003) Human KIR sequences 2003. IMMUNOGENETICS , 55 (4) pp. 227-239. 10.1007/s00251-003-0572-y.

Garcia, CA; Robinson, J; Madrigal, JA; Marsh, SGE; (2003) Natural killer cell receptors: Functional roles. Inmunologia , 22 (2) pp. 190-202.

Gerrard, G; Ganeshaguru, G; Payne, B; Baker, R; McCullough, H; Jones, DT; Potter, M; ... Mehta, A; + view all (2003) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride. In: (Proceedings) 5th International Symposium on Leukemia and Lymphoma. (pp. p. 665). NATURE PUBLISHING GROUP

Ginhoux, F; Doucet, C; Leboeuf, M; Lemonnier, FA; Danos, O; Davoust, J; Firat, H; (2003) Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy. Mol Ther , 8 (2) pp. 274-283.

Glassford, J; Soeiro, I; Koyasu, S; Lam, EWEA; (2003) BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene , 22 (15) pp. 2248-2259.

Godfrey, A; Laman, H; Boshoff, C; (2003) RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus. CURR OPIN INFECT DIS , 16 (6) 593 - 600. 10.1097/01.qco.0000104301.87920.4a.

Grandage, VL; Linch, DC; Khwaja, A; (2003) P13Kinase is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NFkB, MAPKinase and P53 pathways. In: BLOOD. (pp. 585A - 585A). AMER SOC HEMATOLOGY

Gribble, SM; Reid, AG; Bench, AJ; Huntly, BJP; Grace, C; Green, AR; Nacheva, EP; (2003) Molecular cytogenetics of polycythaemia vera: lack of occult rearrangements detectable by 20q LSP screening, CGH, and M-FISH. In: LEUKEMIA. (pp. 1419 - 1421). NATURE PUBLISHING GROUP

Grigg, A; Solal-Celigny, P; Hoskin, P; Taylor, K; McMillan, A; Forstpointner, R; Bacon, P; ... Hiddemann, W; + view all (2003) Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma. Leukemia and Lymphoma , 44 (9) pp. 1503-1508.

Grimshaw, GM; Szczepura, A; Hultén, M; MacDonald, F; Nevin, NC; Sutton, F; Dhanjal, S; (2003) Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess , 7 (10) pp. 1-146.

Gross, D-A; Leboeuf, M; Gjata, B; Danos, O; Davoust, J; (2003) CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood , 102 (13) pp. 4326-4328. 10.1182/blood-2003-05-1454.

H

Hackshaw, A; (2003) Paper does not diminish conclusion of previous reports. On behalf of the International Agency for Research on Cancer Working Group on Smoking and Involuntary smoking. BMJ (Clinical Research Ed.) , 327 pp. 501-502.

Hackshaw, AK; (2003) The EUSOMA review on mammography screening. In: Proceedings from the Global Summit on Mammographic Screening, Milan 2002. Annals of Oncology , 14 pp. 1193-1195.

Hadjur, S; Jirik, FR; (2003) Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. BLOOD , 101 (10) 3877 - 3884.

Hajioff, D; Goodwin, S; Quiney, R; Zuckerman, J; MacDermot, KD; Mehta, A; (2003) Hearing improvement in patients with Fabry disease treated with agalsidase alfa. Acta Paediatr Suppl , 92 (443) pp. 28-30.

Hamidi, AEL; Kocjan, G; Du, MQ; (2003) Clonality analysis of archival cervical smear: monocloniality correlates with grade and clinical behaviour of CIN. Acta Cytologica , 47 pp. 117-123.

Harney, J; Goodchild, K; Phillips, H; Glynne-Jones, R; Hoskin, PJ; Saunders, MI; (2003) A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. Clinical Oncology , 15 (3) pp. 109-114.

Harney, J; Shah, N; Short, S; Saunders, M; Joiner, M; (2003) Low dose hyper-radiosensitivity-a clinical assessment. In: (pp. Abs 173-).

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. BRIT J HAEMATOL , 120 (6) 944 - 952.

Horton, MA; Massey, HM; Flanagan, AM; (2003) Upregulation of à2á1 Integrin in á3 null type Glanzmann thrombasthenia enables bone resorption. British Journal of Haematology , 122 pp. 950-957.

Horton, R; Beck, S; (2003) Accessing HLA sequencing data through the 6ace database. Methods Mol Biol , 210 pp. 23-42.

Horwood, E; Dowson, H; Gupta, R; Kaczmarski, R; Williamson, M; (2003) Myelofibrosis presenting as spinal cord compression. J Clin Pathol , 56 (2) pp. 154-156.

Hoskin, PJ; (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treatment Reviews , 29 (4) pp. 321-327.

Hoskin, PJ; (2003) Case selection in the management of cerebral metastases. Clinical Oncology , 15 (7) pp. 420-421.

Hoskin, PJ; (2003) What are the oncologist's need. European Journal of Nuclear Medicine and Molecular Imaging , 30 (S1) S37-S41. 10.1007/s00259-003-1158-5.

Hoskin, PJ; (2003) Radiotherapy in symptom management. In: Doyle, D and Hanks, GW and Cherny, N and Calman, K, (eds.) Oxford Textbook of Palliative Care. Oxford University Press.: Oxford.

Hoskin, PJ; (2003) Evaluation and management of the patient with bone metastases at presentation. In: Jasmin, C and Caanna, R and Coia, L and Coleman, R and Diel, I, (eds.) Textbook of Bone Metastases. Wiley: Chichester.

Hoskin, PJ; Bownes, PJ; Ostler, P; Walker, K; Bryant, L; (2003) High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiotherapy And Oncology , 68 (3) pp. 285-288.

Hoskin, PJ; Grover, A; Bhana, R; (2003) Metastatic spinal cord compression: radiotherapy outcome and dose fractionation. Radiotherapy And Oncology , 68 (2) pp. 175-180.

Hoskin, PJ; O'Doherty, MJ; (2003) Lymphoma: Diagnosis and Management. European Journal Of Nuclear Medicine and Molecular Imaging , 30 (S1) BP87-BP98. 10.1007/s00259-003-1342-7.

Hoskin, PJ; Sibtain, A; Daley, FM; Wilson, GD; (2003) GLUTI and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. British Journal of Cancer , 89 (7) pp. 1290-1297. 10.1038/sj.bjc.6601260.

Howie, AJ; Turhan, N; Adu, D; (2003) Powerful morphometric indicator of prognosis in lupus nephritis. QJM , 96 (6) pp. 411-420. 10.1097/01.TP.0000120177.44144.FF.

Hughes, SE; (2003) Detection of apoptosis by in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon. The Journal of Pathology (201) pp. 181-186.

Huhalov, A; Spencer, DI; Chester, KA; (2003) Mapping Antibody:Antigen Interactions by Mass Spectrometry and Bioinformatics. In: Lo, BKC, (ed.) Antibody Engineering Methods and Protocols. (pp. 465-480). Humana Press

Hulten, MA; Dhanjal, S; Pertl, B; (2003) Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. REPRODUCTION , 126 (3) 279 - 297.

Hunter, HM; Peggs, K; Powles, R; Apperley, J; Mahendra, P; Cavenagh, J; Littlewood, T; ... Russell, NH; + view all (2003) A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma. In: (pp. 2705-).

Hunter, HM; Peggs, K; Powles, R; Apperley, J; Mahendra, P; Cavenagh, J; Littlewood, T; ... Russell, NH; + view all (2003) A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma. In: BLOOD. (pp. 732A - 732A). AMER SOC HEMATOLOGY

Huntly, BJP; Guilhot, F; Reid, AG; Vassiliou, G; Hennig, E; Franke, C; Byrne, J; ... Deininger, MWN; + view all (2003) Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. In: BLOOD. (pp. 2205 - 2212). AMER SOC HEMATOLOGY

I

Irwin, HL; Corcoran, F; Boxer, GM; Pedley, RB; Dearling, J; Hartley, JM; Begent, RHJ; (2003) Isolation of tumour cells from peripheral blood for potential assessment of response to antibody directed enzyme prodrug therapy (ADEPT). British Journal of Cancer , 88 S37-S37.

J

Jacqui, T; (2003) Thalidomide used to fight lung cancer. ‘Deformity’ drug in new trial. The Sun 16-.

James, L; Lee, SM; (2003) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) 10th World Conference on Lung Cancer, Vancouver.. (pp. S183-). Lung Cancer

James, M; (2003) Lung cancer curbed in thalidomide trial. The Guardian

Jarvis, M; Marzolini, M; Wang, XN; Jackson, G; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: Correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. TRANSPLANTATION , 76 (5) pp. 849-853. 10.1097/01.TP.0000083556.73555.78.

Jarvis, M; Marzolini, MAV; Wang, XN; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: Correlation of expression with degree of graft-versus-host response and clinical GVHD: Quantitative assessment using laser scanning confocal microscopy. In: (Proceedings) 17th European Histocompatability Conference/11th Annual Meeting of the German-Society-of-Immunogenetics. (pp. S47-S47). NATURE PUBLISHING GROUP

John, G; (2003) Thalidomide. An unlikely cure? Guardian 60-.

John, T; Ottley, C; Pearson, G; Nowell, G; Calvert, H; Tilby, M; (2003) Sensitive determination of BBR 3464 and cisplatin DNA adduct levels in clinical samples using ICP-MS and PIMMS. In: BRITISH JOURNAL OF CANCER. (pp. S42 - S42). NATURE PUBLISHING GROUP

Jones, C; Mackay, A; Grigoriadis, A; Cossu, A; Reis, JS; Fulford, LG; Dexter, T; ... Lakhani, SR; + view all (2003) Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S12 - S12). KLUWER ACADEMIC PUBL

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; ... Wickremasinghe, RG; + view all (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. BLOOD , 101 (8) 3174 - 3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; ... Wickremasinghe, RG; + view all (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood , 101 (8) pp. 3174-3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. BRIT J HAEMATOL , 121 (5) 713 - 720.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol , 121 (5) pp. 713-720.

Joshi, C; Enver, T; (2003) Molecular complexities of stem cells. CURRENT OPINION IN HEMATOLOGY , 10 (3) pp. 220-228. 10.1097/00062752-200305000-00005.

K

Kalra, D; Singleton, P; Ingram, D; Milan, J; Mackay, J; Detmer, D; Rector, A; (2003) Security and confidentiality approach for the Clinical E-Science Framework (CLEF). In: Cox, S, (ed.) Proceedings of UK e-Science All Hands Meeting 2003. (pp. 825-832). Engineering and Physical Sciences Research Council (EPSRC)

Karzynski, M; Mateos, A; Herrero, J; Dopazo, J; (2003) Using a genetic algorithm and a perceptron for feature selection and supervised class learning in DNA microarray data. ARTIFICIAL INTELLIGENCE REVIEW , 20 (1-2) pp. 39-51. 10.1023/A:1026032530166.

Kate, N; (2003) Bag Drug Makes Good. TIME Magazine 59-.

Kauppila, S; Maaty, WSA; Chen, P; Tomar, RS; Eby, MT; Chapo, J; Chew, S; ... Chaudhary, PM; + view all (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene , 22 (31) pp. 4860-4867. 10.1038/sj.onc.1206715.

Kellam, P; Holzerlandt, R; Gramoustianou, E; Jenner, R; Kwan, A; (2003) Viral bioinformatics: computational views of host and pathogen. Novartis Found Symp , 254 pp. 234-247.

Kerr, D; McArdle, C; Ledermann, J; Taylor, I; (2003) Hepatic artery chemotherapy and colorectal liver metastases - Reply. The Lancet , 361 (9370) p. 1743.

Kerr, D; McArdle, C; Ledermann, J; Taylor, I; (2003) Hepatic artery chemotherapy and colorectal liver metastases - Reply. LANCET , 361 (9370) 1743 - 1743.

Keshtgar, MR; Stein, RC; (2003) Breast cancer. [Book]. Patient's pictures. (1st ed.). Health Press Limited: Oxford.

Khalil, AA; Bentzen, SM; Bernier, J; Saunders, MI; Horiot, JC; Van Den Bogaert, W; Cummings, BJ; (2003) Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. International Journal of Radiation Oncology Biology Physics , 55 (3) pp. 568-575.

Khan, K; Kostoula, V; Savage, K; Stubbs, M; McStay, M; Dhillon, AP; Caplin, ME; (2003) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? In: (pp. 333-).

Kichler, A; Leborgne, C; März, J; Danos, O; Bechinger, B; (2003) Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci U S A , 100 (4) pp. 1564-1568. 10.1073/pnas.0337677100.

Kichler, A; Sabourault, N; Décor, R; Leborgne, C; Schmutz, M; Valleix, A; Danos, O; ... Mioskowski, C; + view all (2003) Preparation and evaluation of a new class of gene transfer reagents: poly(-alkylaminosiloxanes). J Control Release , 93 (3) pp. 403-414.

Kim, SH; Parrinello, S; Kim, J; Campisi, J; (2003) Mus musculus and Mus spretus homologues of the human telomere-associated protein TIN2. GENOMICS , 81 (4) 422 - 432. 10.1016/S0888-7543(02)00033-2.

Kocjan, G; (2003) Fine needle aspiration cytology. Cytopathology , 14 (6) pp. 307-308.

Kostoula, V; Khan, K; Savage, K; Hochhauser, D; Stubbs, M; McStay, M; Dhillon, AP; (2003) Expression of c-kit (cd117) in neuroendocrine tumours - a target for therapy? ENDOCR-RELAT CANCER , 10 (4) 508 - 508.

Kotecha, MT; Hercus, L; Lees, SM; Hartley, JA; Hochhauser, D; (2003) Modulation of topoisomerase Iia expression by sequence specific polyamides. In: (pp. 6539-).

Kottaridis, PD; Gale, RE; Linch, DC; (2003) FLT3 mutations and leukaemia. British Journal of Haematology , 122 (4) pp. 523-538. 10.1046/j.1365-2141.2003.04500.x.

Krause, M; Hessel, F; Wohlfarth, J; Zips, D; Hoinkis, C; Foest, H; Short, S; ... Baumann, M; + view all (2003) Ultrafractionation in A7 malignant glioma in nude mice. pp. 377-383.

Krishnan, B; Ganeshaguru, K; Baker, R; Richfield, L; Mehta, AB; (2003) Multidrug resistance and myelomonocytic leukaemia in gaucher's disease. Haematologica , 88 (2) ECR02-. Green open access
file

Kristeleit, RS; Stimson, L; Workman, P; Aherne, GW; (2003) Effects of the hydroxamic acid histone deacetylase inhibitors trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA) and LAQ824 on histone and protein acetylation. In: CLINICAL CANCER RESEARCH. (pp. 6107S - 6107S). AMER ASSOC CANCER RESEARCH

Kyriakou, CA; D'Sa, SP; Flory, A; Hanslip, J; Peggs, KS; Yong, KL; (2003) Cyclophosphamide, dexamethasone and thalidomide (CDT) is a well tolerated and effective regimen in advanced relapsed/refractory myeloma. In: (pp. 5270-).

Kyriakou, CA; D'Sa, SP; Flory, A; Hanslip, J; Peggs, KS; Yong, KL; (2003) Cyclophosphamide, dexamethasone and thalidomide (CDT) is a well tolerated and effective regimen in advanced relapsed/refractory myeloma. In: BLOOD. (pp. 386B - 386B). AMER SOC HEMATOLOGY

Kyriakou, CA; Yong, KL; Benjamin, R; Gandini, D; Davidoff, AM; Nathwani, AC; (2003) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral mediated gene transfer inhibit growth of Burkitt's lymphoma in murine models. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

L

Lacombe, D; Butler-Smith, A; Therasse, P; Fumoleau, P; Burtles, S; Calvert, H; Marsoni, S; ... Verweij, J; + view all (2003) Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network. CANCER INVEST , 21 (1) 137 - 147. 10.1081/CNV-120016408.

Ledermann, JA; Colombo, N; du Bois, A; Torri, V; Floriani, I; Qian, W; Adams, HP; ... ICON AGO Collaborators, ; + view all (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003). LANCET , 362 (9394) 1504 - 1504.

Ledermann, JA; ICON Collaborators, ; AGO Collaborators, ; (2003) Randomised trial of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer (ICON4/OVAR 2.2). BRITISH JOURNAL OF CANCER , 88 S9 - S9.

Lee, AC; Chicken, DW; Pickard, CDO; Briggs, GM; Kocjan, G; Falzon, M; Bigio, I; ... Bown, SG; + view all (2003) Comparative study of elastic scattering spectroscopy and touch imprint cytology in assessing sentinel lymph node status in breast cancer. In: BRITISH JOURNAL OF SURGERY. (pp. 112 - 112). JOHN WILEY & SONS LTD

Lee, AC; Pickard, CDO; Briggs, GM; Sainsbury, JR; Falzon, M; Kocjan, G; Bigio, I; ... Keshtgar, MRS; + view all (2003) Intra-operative assessment by optical biopsy for sentinel lymph node metastasis in breast cancer: update and comparison with imprint cytology. BRITISH JOURNAL OF SURGERY , 90 (5) 625 - 626.

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I phosphoinositide 3-kinase p110 beta is required for apoptotic cell and Fc gamma receptor-mediated phagocytosis by macrophages. JOURNAL OF BIOLOGICAL CHEMISTRY , 278 (40) pp. 38437-38442. 10.1074/jbc.M306649200. Gold open access

Lewis, I; Nooij, M; Whelan, J; Casak, S; Memon, M; Taminiau, A; Hogendoorn, P; ... Intergroup, AKOBOTEO; + view all (2003) Chemotherapy at standard or increased dose intensity in patients with operable osteosarcoma of the extremity: A randomised controlled trial of the European Osteosarcoma Intergroup (ISRCTN 86294690). In:

Lipton, L; Halford, SE; Johnson, V; Novelli, MR; Jones, A; Cummings, C; Barclay, E; ... Tomlinson, IP; + view all (2003) Carcinogenesis in MYH-Associated Polyposis Follows a Distinct Genetic Pathway. Cancer Research , 63 (22) pp. 7595-7599.

Love, EM; Jones, H; Williamson, LM; Cohen, H; (2003) SHOT – a voluntary system for the reporting of serious hazards of transfusion in the UK. Transfusion and transfusion alternatives , 5 pp. 248-255.

Lowdell, MW; (2003) "Out damned spot": ex vivo purging revisited. BLOOD , 102 (12) 3860 - 3861.

Lu, X; (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nature Genetics , 33 pp. 162-167.

Luong, QT; Hills, RK; Drayson, MT; Wheatley, K; Burnett, AK; Linch, DC; Bunce, CM; (2003) Expression of Nm23-H1 in AML correlates with white cell count at diagnosis and in vitro acts as a survival factor for primary AMLs cells; Evidence of a novel autocrine survival factor in AML. BLOOD , 102 (11) 2255-.

Lyn, BE; Wilson, EM; Williams, FJ; Saunders, MI; Phillips, H; (2003) Chart to Chartwel to Chemotherapy and Chartwel in Non-Small Cell Lung Cancer. British Journal of Cancer , 88 S23-S23.

M

MacDonald, D; Henderson, S; Boustead, GB; Boshoff, C; (2003) A pilot study of gene expression analysis of recurrence in superficial bladder cancer. European Urology Supplements , 2 (1) p. 219.

Machin, SJ; (2003) Pros and cons of thrombophilia testing: cons. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 1 (3) pp. 412-413. 10.1046/j.1538-7836.2003.00168.x.

Mackay, HJ; O'Brien, M; Hill, S; Lee, SM; Thatcher, N; Smith, IE; Dunlop, DJ; (2003) A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer. Clinical Oncology , 15 (4) pp. 181-185.

Macropoulos, P; Sieben, N; Kolkman-Uljee, SM; Al Adani, M; Roemen, MJM; de Goeij, APM; Fleuren, J; ... Flanagan, AM; + view all (2003) RAF/RAS mutations in ovarian neoplasms. In: (Proceedings) 2nd Joint Meeting of the British Division of the International-Academy-of-Pathology/185th Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. 11A-11A). WILEY-BLACKWELL

Madhusudan, S; Braybrooke, JP; Forster, M; Wilner, S; Han, C; Kaur, K; Balkwill, F; ... Harris, AL; + view all (2003) A phase II Trial of etanercept a recombinant human soluble tumour necrosis factor receptor (p75) fusion protein in patients with metastatic breast cancer. In: (Proceedings) AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. (pp. 6192S-6192S). AMER ASSOC CANCER RESEARCH

Madrigal, JA; Garcia, CA; Gutierrez, ME; Shaw, BE; Arguello, A; Jr, L; A M, M; (2003) El complejo mayor de histocompatibilidad y su papel biologico. HLA y su papel en la evolucion clinica de transplantes y enfermedades autoinmunes. In: Garcia-Conde, JJ and San Migual, JF and Sierra, J and Urbano-Ispizua, A and Vicente, V and Vives Corrons, JL, (eds.) Hematologia. (pp. 105-112). Aran Edcines: Madrid.

Madrigal, JA; Garcia, CA; Gutierrez, ME; Shaw, BE; Arguello, A; Little, AM; March, SGE; (2003) El complejo mayor de histocompatibilidad y su papel biologico. HLA y su papel en la evolucion clinica de transplantes y enfermedades autoinmunes. In: Garcia-Conde, JJ and San Migual, JF and Sierra, J and Urbano-Ispizua, A and Vicente, V and Vives Corrons, JL, (eds.) Hematologia. (pp. 105-112). Aran Edcines: Madrid.

Makris, A; (2003) Critical commentary of: Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin and flourouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer:an EORTC-NCIC-SAKK multicenter study. Women's Oncology Review , 3 pp. 237-238.

Marafioti, T; Jones, M; Facchetti, F; Diss, T; Du, MQ; Issacson, PG; Pozzobon, M; ... Mason, DY; + view all (2003) Interfollicular large B-cells: a subpopulation that may give rise to human lymphomas. BLOOD , 102 pp. 2868-2876.

Marafioti, T; Jones, M; Facchetti, F; Diss, TC; Du, MQ; Isaacson, PG; Pozzobon, M; ... Mason, DY; + view all (2003) Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. BLOOD , 102 (8) pp. 2868-2876. 10.1182/blood-2003-03-0692.

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. Blood , 102 (11) 964-.

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: (pp. 964-).

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. BLOOD , 102 (11) 3591-.

Marden, CM; North, J; Little, AM; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. In: BLOOD. (pp. 964A - 964A). AMER SOC HEMATOLOGY

Marinovich, M; Binaglia, M; Viviani, B; Bartesaghi, S; Galli, CL; (2003) The dithiocarbamate propineb depolymerizes actin and increases acetylcholine release in differentiated PC12 cells. In: TOXICOLOGICAL SCIENCES. (pp. 267 - 268). OXFORD UNIV PRESS

Marks, AJ; Cooper, M; Orchard, K; Folarin, NI; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; (2003) Targeted therapy with an amphipathic peptide results in selective apoptotic cell death in CD19 positive chronic lymphocytic leukemia cells. BLOOD , 102 (11) 247-.

Marsh, SGE; (2003) HLA nomenclature and the IMGT/HLA sequence database. In: UNSPECIFIED (pp. 165-173).

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update June 2003. Hum Immunol , 64 (9) pp. 919-920.

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update May 2003. Hum Immunol , 64 (9) pp. 917-918.

Marsh, SGE; (2003) Nomenclature for factors of the HLA system, update September 2003. Eur J Immunogenet , 30 (6) 437-.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Hum Immunol , 64 (6) pp. 656-657.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Hum Immunol , 64 (6) 655-.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2002. Hum Immunol , 64 (1) pp. 180-181.

Marsh, SGE; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2002. Hum Immunol , 64 (1) 179-.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Witt, C; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. JOURNAL OF IMMUNOLOGICAL METHODS , 281 (1-2) pp. 1-8. 10.1016/j.jim.2003.08.001.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. IMMUNOGENETICS , 55 (4) pp. 220-226. 10.1007/s00251-003-0571-z.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol , 64 (6) pp. 648-654.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Eur J Immunogenet , 30 (3) 237-.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Eur J Immunogenet , 30 (3) 235-.

Marsh, SGE; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Eur J Immunogenet , 30 (3) 239-.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Tissue Antigens , 62 (1) pp. 89-90.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Tissue Antigens , 62 (1) pp. 87-88.

Marsh, SGE; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Tissue Antigens , 62 (1) pp. 91-92.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Eur J Immunogenet , 30 (4) pp. 299-300.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Tissue Antigens , 62 (4) pp. 333-334.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update August 2002. Eur J Immunogenet , 30 (1) 91-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Tissue Antigens , 61 (5) pp. 412-413.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Eur J Immunogenet , 30 (2) 167-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update July 2002. Eur J Immunogenet , 30 (1) 89-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Eur J Immunogenet , 30 (4) pp. 303-304.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Tissue Antigens , 62 (4) pp. 337-338.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Tissue Antigens , 62 (4) pp. 335-336.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Eur J Immunogenet , 30 (4) 301-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Eur J Immunogenet , 30 (2) pp. 165-166.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Tissue Antigens , 61 (5) pp. 410-411.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Eur J Immunogenet , 30 (1) 95-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Tissue Antigens , 61 (5) pp. 408-409.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update September 2002. Eur J Immunogenet , 30 (1) pp. 93-94.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, April 2003. Hum Immunol , 64 (8) pp. 835-836.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, September 2002. Hum Immunol , 64 (5) pp. 572-573.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2003. Hum Immunol , 64 (12) 1197-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2003. Hum Immunol , 64 (12) pp. 1195-1196.

Martin, F; Chowdhury, S; Neil, SJ; Chester, KA; Cosset, FL; Collins, MK; (2003) Targeted retroviral infection of tumor cells by receptor cooperation. J VIROL , 77 (4) 2753 - 2756. 10.1128/JVI.77.4.2753-2756.2003.

Martin, MJ; Herrero, J; Mateos, A; Dopazo, J; (2003) Comparing bacterial genomes through conservation profiles. GENOME RESEARCH , 13 (5) pp. 991-998. 10.1101/gr.678303.

Mason, C; Markusen, JF; Boshoff, CH; (2003) Methods employing cells derived from adult bone marrow.

Mayer, A.; Tsiompanou, E.; Flynn, A.A; Pedley, R.B.; Dearling, J.; Boden, R.; Begent, R.H.J.; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. Cancer Investigation , 21 (3) pp. 382-388. 10.1081/CNV-120018229.

Mburu, P; Mustapha, M; Varela, A; Weil, D; El-Amraoui, A; Holme, RH; Rump, A; ... Brown, SDM; + view all (2003) Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat Genet , 34 (4) pp. 421-428. 10.1038/ng1208.

McCormick, AL; Benjamin, R; Pizzey, A; Kyriakou, C; Nathwani, AC; (2003) Facilitation of lentivirus mediated gene transfer into primary human and murine progenitors by Antp peptide. In: BLOOD. (pp. 995A - 995A). AMER SOC HEMATOLOGY

Mcgonigle, G; Glasow, A; Grier, D; Enver, T; Zelent, A; Thompson, A; (2003) Regulation of Hox genes by Il-3 in 32D and FDCP-mix cells. In: (Proceedings) 32nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology. (pp. p. 218). ELSEVIER SCIENCE INC

Mehta, A; (2003) Self-Assessment Colour Review of Clinical Haematology. [Book]. Manson Publishing

Mehta, A; (2003) The inner ear in Fabry disease. Acta Paediatrica , 92 p. 27.

Mehta, AB; Lewis, S; Laverey, C; (2003) Treatment of lysosomal storage disorders. BMJ (Clinical Research Ed.) , 30 (327) pp. 462-463.

Mela, M; Raimondo, ML; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; Patch, D; (2003) Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates. Journal of Hepatology , 38 129-.

Mela, M; Raimondo, ML; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; Patch, D; (2003) Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates. In: (pp. 129-).

Melo, JV; Tipping, AJ; (2003) Location matters... BLOOD , 102 (6) 1941 - 1942.

Meyer, T; McTiernan, A; Whelan, J; (2003) A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours. Sarcoma , 7 (1) pp. 13-17. 10.1080/1357714031000114192. Gold open access

Mitsiadis, TA; Angeli, I; James, C; Lendahl, U; Sharpe, PT; (2003) Role of Islet1 in the patterning of murine dentition. Development , 130 (18) pp. 4451-4460.

Morton, PE; Ng, TC; Roberts, SA; Vojnovic, B; Ameer-Beg, SM; (2003) Time resolved multiphoton imaging of the interaction between the PKC and NFκB signalling pathways. Proceedings of SPIE - The International Society for Optical Engineering , 5139 pp. 216-222.

Mumford, AD; McVey, JH; Morse, CV; Gomez, K; Steen, M; Norstrom, EA; Tuddenham, EGD; ... Bolton-Maggs, PHB; + view all (2003) Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol , 123 (3) pp. 496-501.

Murphy, DM; Dolbear, C; Moller, H; Whelan, JS; Pinkerton, CR; (2003) The incidence of cancer in adolescents and young adults in south east England: an analysis of Thames Cancer Registry data 1998-2000. In:

Mörner, A; Thomas, JA; Björling, E; Munson, PJ; Lucas, SB; McKnight, A; (2003) Productive HIV-2 infection in the brain is restricted to macrophages/microglia. AIDS , 17 (10) pp. 1451-1455. 10.1097/01.aids.0000076269.76134.c7.

N

Nash, M; Camilleri, R; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein 1 (anti-beta2GP1) polymorphism and antibodies to anti-beta2GP1. In: (Proceedings) International society of thrombosis and haemostasis.

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies. BRIT J HAEMATOL , 120 (3) 529 - 531.

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and anti-beta2GPI antibodies. British Journal of Haematology , 120 (3) pp. 529-531. 10.1046/j.1365-2141.2003.04130.x.

Nathan, PD; Hochhauser, D; (2003) Pathogenesis of Cancer. In: Kirk, RM and Ribbans, WJ, (eds.) Clinical Surgery in General. Charchill Livingstone: London.

Newman, G; (2003) ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit. Lancet , 362 (9392) 1333-. 10.1016/S0140-6736(03)14602-8.

Newton, R; Ziegler, J; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; ... Uganda Sarcoma Study Grp, ; + view all (2003) Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. BRIT J CANCER , 89 (3) 502 - 504. 10.1038/sj.bjc.6601113.

Nooij, M; Lewis, I; Whelan, JS; Casak, S; Memon, M; Hogendoorn, P; Weeden, S; ... Kirkpatrick, A; + view all (2003) Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI). In:

Novelli, M; Preston, SL; Kyriakides, E; Oukrif, D; Tomlinson, I; Poulson, R; Wright, NA; (2003) Intra-villous adenomas in the duodenum of patients with familial adenomatous polyposis (FAP): Implications for the origins of adenomas and for the relevance of mouse models for intestinal neoplasia. In: JOURNAL OF PATHOLOGY. (pp. 5A - 5A). JOHN WILEY & SONS LTD

Novelli, M; Preston, SL; Kyriakides, E; Oukrif, D; Tomlinson, I; Poulson, R; Wright, NA; (2003) Intra-villous adenomas in the duodenum of patients with familial adenomatous polyposis (FAP): Implications for the origins of adenomas and for the relevance of mouse models for intestinal neoplasia. In: GASTROENTEROLOGY. (pp. A132 - A132). W B SAUNDERS CO

O

Orleans-Lindsay, JK; Deru, A; Craig, JIO; Prentice, HG; Lowdell, MW; (2003) In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. CLIN EXP IMMUNOL , 133 (3) 467 - 475.

Otth, C; Mendoza-Naranjo, A; Mujica, L; Zambrano, A; Concha, II; Maccioni, RB; (2003) Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease. NEUROREPORT , 14 (18) 2403 - 2409. 10.1097/01.wnr.0000099988.54721.3c.

Ouyang, Q; Wagner, WM; Wikby, A; Walter, S; Aubert, G; Dodi, A; Travers, P; (2003) Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. Journal of Clinical Immunology , 23 (4) pp. 247-257.

P

Pallier, C; (2003) Association of Chromatin Proteins High Mobility Group Box (HMGB) 1 and HMGB2 with Mitotic Chromosomes. Molecular Biology of the Cell , 14 (8) pp. 3414-3426. 10.1091/mbc.E02-09-0581.

Pamphilon, DH; Lowdell, MW; (2003) Stem cells and immunotherapy. TRANSFUSION MED , 13 (6) 323 - 324.

Parmar, M.K.; Ledermann, J.A.; Colombo, N.; du Bois, A.; Delaloye, J.F.; (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. The Lancet , 361 (9375) pp. 2099-2106. 10.1016/S0140-6736(03)13718-X.

Paston, SJ; Dodi, IA; Travers, PJ; Madrigal, JA; (2003) The role of HLA-B alleles in CMV peptide epitope presentation. Is there a hierarchy in HLA presentation of CMV epitopes: 14th Annual BSHI conference abstracts. EUR J IMMUNOGEN , 30 (4) pp. 305-323.

Paston, SJ; Dodi, IA; Travers, PJ; Madrigal, JA; (2003) The role of HLA-B alleles in CMV peptide epitope presentation. Is there a hierarchy in HLA presentation of CMV epitopes: 14th Annual BSHI conference abstracts. European Journal of Immunogenetics , 30 (4) pp. 305-323.

Peggs, K.S.; Mackinnon, S.; Williams, C.D.; D'Sa, S.; Thuraisundaram, D.; Kyriakou, C.; Morris, E.C.; ... Yong, K.; + view all (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Biology of Blood and Marrow Transplantation , 9 (4) pp. 257-265. 10.1053/bbmt.2003.50009.

Penny, D; Henderson, SM; Brown, PJ; (2003) Raisin poisoning in a dog. The Veterinary record , 152 (10) p. 308.

Pepys, M.B.; Bybee, A.; Booth, D.R.; Bishop, M.T.; Will, R.G.; Little, A.-M; Prokupek, B.; (2003) MHC typing in variant Creutzfeldt-Jakob disease. The Lancet , 361 (9356) pp. 487-489. 10.1016/S0140-6736(03)12455-5.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) pp. 487-489.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) 487 - 489.

Pereira, SP; Falzon, M; Kocjan, G; Novelli, M; (2003) Prospective comparison of endoscopic ultrasound guided 22G fine needle aspiration (EUS-FNA) with 19G trucut needle biopsy (EUS-TNB). In: GUT. (pp. A26 - A26). BRITISH MED JOURNAL PUBL GROUP

Porakishvili, N; Kulikova, N; Jewell, AP; Youinou, PY; Yong, K; Nathwani, A; Heelan, B; ... Lydyard, PM; + view all (2003) Preferential expression of CD180 by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated versus those using IgVh unmutated genes. In: (pp. S17-).

Poulsom, R; Campbell, V; Jeffery, R; Hunt, T; Alison, MR; Dhillon, AP; Quaglia, AF; (2003) Hepatocytes bearing the Philadelphia chromosome: Evidence for transdifferentiation of bone marrow to liver without transplantation. In: JOURNAL OF PATHOLOGY. (pp. 4A - 4A). JOHN WILEY & SONS LTD

Poulsom, R; Campbell, V; Jeffery, R; Hunt, T; Alison, MR; Quaglia, A; Dhillon, AP; (2003) Hepatocytes bearing the Philadelphia chromosome reveal transdifferentiation of bone marrow to liver without transplantation. In: (pp. 205-).

Pratten, J; Pasu, M; Jackson, G; Flanagan, A; Wilson, M; (2003) Modetting oral malodour in a longitudinal study. ARCH ORAL BIOL , 48 (11) 737 - 743. 10.1016/S0003-9969(03)00154-7.

Presneau, N; Manderson, EN; Tonin, PN; (2003) The quest for a tumor suppressor gene phenotype. CURR MOL MED , 3 (7) 605 - 629.

Presneau, N; Mes-Masson, AM; Ge, B; Provencher, D; Hudson, TJ; Tonin, PN; (2003) Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines. ONCOGENE , 22 (10) 1568 - 1579. 10.1038/sj.onc.1206219.

Preston, SL; Wong, W; Chan, A; Poulsom, R; Jeffery, R; Goodlad, RA; Mandir, N; ... Wright, NA; + view all (2003) Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Research , 63 (13) pp. 3819-3825.

Puntervoll, P; Linding, R; Gemund, C; Chabanis-Davidson, S; Mattingsdal, M; Cameron, S; Martin, DM; ... Gibson, TJ; + view all (2003) ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Research , 31 (13) 3625 - 3630. 10.1093/nar/gkg545. Green open access
file

Q

Quaglia, A; Jutand, MA; Dhillon, A; Godfrey, A; Colombari, R; Togni, R; Dalla Palma, P; ... Dhillon, AP; + view all (2003) A novel algorithm for the histological assessment of hepatocellular carcinoma and its putative precursor nodular lesions in cirrhotic liver. In: JOURNAL OF PATHOLOGY. (pp. 21A - 21A). JOHN WILEY & SONS LTD

Quaglia, A; Tibballs, J; Grasso, A; Prasad, N; Nozza, P; Davies, SE; Burroughs, AK; ... Dhillon, AP; + view all (2003) Focal nodular hyperplasia-like areas in cirrhosis. HISTOPATHOLOGY , 42 (1) 14 - 21.

R

Redpath, JL; Short, SC; Woodcock, M; Johnston, P; (2003) Low dose reduction in transformation frequency compared to unirradiated controls: the role of hyper-radiosensitivity. Radiation Research , 159 pp. 433-436.

Reid, AG; Tarpey, PS; Nacheva, EP; (2003) High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes. GENE CHROMOSOME CANC , 37 (3) 282 - 290. 10.1002/gcc.10215.

Reigner, B; Watanabe, T; Schuller, J; Lucraft, H; Sasaki, Y; Bridgewater, J; Saeki, T; ... Grange, S; + view all (2003) Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 52 (3) pp. 193-201. 10.1007/s00280-003-0642-8.

Richards, M; Ponder, M; Everest, S; Pharoah, P; Mackay, J; (2003) Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. Journal of Medical Ethics , 29 pp. 93-96.

Rob, B; (2003) Controversial drug in lung cancer trials. Highbury & Islington Express

Roberts, C; Robinson, J; Dodi, IS; Madrigal, JA; Marsh, SGE; (2003) The European Searchable Tumour Cell Line Database (ESTDAB). In: (pp. 321-).

Robinson, J; Marsh, SGE; (2003) HLA informatics. Accessing HLA sequences from sequence databases. In: UNSPECIFIED (pp. 3-21).

Robinson, J; Waller, M; Garcia, C; Stoehr, P; Marsh, SGE; (2003) IPD - The Immuno-Polymorphism Database. In: (pp. 322-).

Rollinson, S; Levene, AP; Mensah, FK; Roddam, PL; Allan, JM; Diss, TC; Roman, E; ... Morgan, GJ; + view all (2003) Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. BLOOD , 102 (3) pp. 1007-1011.

Roos, DE; Davis, SR; Turner, SL; O'Brien, PC; Spry, NA; Burmeister, BH; Hoskin, PJ; (2003) Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiotherapy And Oncology , 67 (2) pp. 207-212.

Rozman, P; Karas, M; Kosir, A; Madrigal, JA; Middleton, D; Navarette, C; Oudshoorn, M; ... Bohinjec, M; + view all (2003) Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation antigens in clinical bone marrow transplantation? BONE MARROW TRANSPLANTATION , 31 pp. 497-506.

S

Sarker, D; Thirlwell, C; Nelson, M; Gazzard, B; Bower, M; (2003) Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma. AIDS , 17 (6) 861 - 865. 10.1097/01.aids.0000050863.71999.f8.

Sarker, D; Williams, MT; Buscombe, J; Caplin, M; Hochhauser, D; Begent, R; Meyer, T; (2003) Streptozocin, 5-fluorouracil/folinic acid and cisplatin (FCiSt) for advanced neuroendocrine tumours. British Journal of Cancer , 88 S65-S65.

Sarker, D; Williams, MT; Buscombe, J; Caplin, M; Hochhauser, D; Begent, R; Meyer, T; (2003) Streptozocin, 5-fluorouracil/folinic acid and cisplatin (FCiSt) for advanced neuroendocrine tumours. In: (Proceedings) British Cancer Research Meeting 2003. (pp. S65-S65). NATURE PUBLISHING GROUP

Saunders, M; Palmer, AM; Millard, RK; Preece, AW; (2003) Doses to fetal and maternal organs from intravenous (FeCl3)-Fe- 59 or (CoCl2)-Co-57. Radiation Protection Dosimetry , 106 (1) pp. 63-69.

Schraml, P; Hergovich, A; Hatz, F; Amin, MB; Lim, SD; Krek, W; Mihatsch, MJ; (2003) Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression. Am J Pathol , 163 (3) pp. 1013-1020.

Sebastiani, G; Wallace, DF; Lioumi, M; Goutos, I; Mitchell, WA; Bomford, AB; Dhillon, AP; ... Walker, AP; + view all (2003) Non HFE-related haemochromatosis: exclusion of the 1q21 zinc-iron regulated transporter-like (ZIRTL) gene in juvenile haemochromatosis. J HEPATOL , 38 (3) 376 - 377. 10.1016/S0168-8278(02)00426-9.

Selvaraju, V; Markandaya, M; Prasad, PVS; Sathyan, P; Sethuraman, G; Srivastava, SC; Thakker, N; (2003) Mutation analysis of the cathepsin C gene in Indian families with Papillon-Lefèvre syndrome. BMC Med Genet , 4 5-. 10.1186/1471-2350-4-5.

Sharma, SK; Pedley, RB; Irwin, HL; El Emir, E; Boxer, GM; Boden, RW; Chester, KA; (2003) The effect of ADEPT, as a single or combined therapy, in two colorectal xenografts. In: (pp. S37-S37).

Shaw, BE; Peggs, K; Bird, JM; Cavenaugh, J; Hunter, A; Madrigal, JA; Russell, NH; ... Marks, DI; + view all (2003) The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. BRIT J HAEMATOLOGY, BR J HAEMATOL , 123 pp. 886-895.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; ... Madrigal, JA; + view all (2003) The degree of matching at HLA-DPB1 predicts for acute graft- versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplantation , 31 (11) pp. 1001-1008.

Shaw, BE; Smith, C; Potter, M; Mayor, N; Marsh, S; Madrigal, J; (2003) TNF alpha promoter polymorphisms may exhibit recombination and have an impact on engraftment in unrelated donor HSCT. In: GENES AND IMMUNITY. (pp. S51 - S51). NATURE PUBLISHING GROUP

Shaw, BE; Smith, C; Potter, MN; Mayor, NP; Marsh, SGE; Madrigal, JA; (2003) TNF alpha promoter polymorphisms have a significant impact on engraftment in unrelated donor hematopoietic stem cell transplant. In: BONE MARROW TRANSPLANTATION. (pp. S60 - S60). NATURE PUBLISHING GROUP

Shaw, BE; Towlson, K; Bird, JM; Madrigal, JA; Cavenagh, J; Marks, DI; British Soc BMT, ; (2003) Unrelated donor hematopoieitic stem cell transplantation for multiple myeloma: a retrospective study by the Clinical Trials Committee of the British Society of BMT and the Anthony Nolan Trust. In: BONE MARROW TRANSPLANTATION. (pp. S149 - S149). NATURE PUBLISHING GROUP

Short, S; (2003) UNSPECIFIED In: (Proceedings) 2nd International Conference on Translational Research in Radiation Oncology.

Short, S; (2003) External beam and conformal radiotherapy in the management of gliomas. In: Westphal, , (ed.) Local therapies for glioma. Springer

Short, S; Buffa, F; Bourne, S; Johnston, P; Bentzen, S; (2003) Determining dose response relationships of gene expression in human tumour cells after low radiation doses using micro-array analysis. In:

Short, S; C, B; F, B; S, J; P, B; S, M; (2003) UNSPECIFIED In: (Proceedings) EU-US Molecular Signatures of DNA Damage Workshop.

Short, S; C, H; J, ; (2003) Radiobiology and vascular targeting in glioma. Current opinion in neurology , 16 pp. 651-655.

Sibtain, A; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2003) Pre-treatment Haemoglobin Concentration in Accelerated and Conventional Radiotherapy for Non-small Cell Lung Carcinoma. Clinical Oncology , 16 pp. 58-62.

Sieben, NLG; Kolkman-Uljee, SM; Flanagan, AM; Le Cessie, S; Cleton-Jansen, AM; Cornelissa, CJ; Fleuren, GJ; (2003) Molecular genetic evidence for monolonal origin of bilateral serous ovarian borderline tumours and implants. American Journal of Pathology , 162 pp. 1095-1101.

Simpson, P; Gale, T; Reis, J; Jones, C; Mackay, A; Bulmer, K; Jones, A; ... Lakhani, SR; + view all (2003) 14-3-3 sigma is a selective myoepithelial cell marker also expressed in basaloid/myoepithelial breast tumours. In: JOURNAL OF PATHOLOGY. (pp. 34A - 34A). JOHN WILEY & SONS LTD

Sinclair, N; Mireskandari, K; Forbes, J; Crow, J; (2003) Merkel cell carcinoma of the eyelid in association with chronic lymphocytic leukaemia. BRITISH JOURNAL OF OPHTHALMOLOGY , 87 (2) p. 240. 10.1136/bjo.87.2.240.

Sinclair, PB; Sorour, A; Martineau, M; Harrison, CJ; Mitchell, W; O'Neill, E; Foroni, L; (2003) A comparative map of 6q deletions in ALL: Identification and analysis of GluR-6 as a candidate tumour suppressor gene. BLOOD , 102 (11) 4518-.

Somervaille, TCP; Linch, DC; Khwaja, A; (2003) Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors. BRIT J HAEMATOL , 120 (5) 876 - 886.

Somervaille, TCP; Linch, DC; Khwaja, A; (2003) Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors. British Journal of Haematology , 120 (5) pp. 876-886. 10.1046/j.1365-2141.2003.04204.x.

Starke, R; Harrison, P; Drummond, O; Macgregor, I; Mackie, I; Machin, S; Simak, J; ... Vostal, JG; + view all (2003) The majority of cellular prion protein released from endothelial cells is soluble [1] (multiple letters). Transfusion , 43 (5) pp. 677-678. 10.1046/j.1537-2995.2003.00405.x.

Starke, R; Harrison, P; Gale, R; Mackie, I; Drummond, O; MacGregor, I; Machin, S; (2003) Endothelial cells express normal cellular prion protein. BRIT J HAEMATOL , 123 (2) 372 - 373.

Stebbing, J; Bourboulia, D; Johnson, M; Henderson, S; Williams, I; Wilder, N; Tyrer, M; ... others, ; + view all (2003) Kaposi’s sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. Journal of virology , 77 (7) pp. 4306-4314.

Stebbing, J; Bourboulia, D; Johnson, M; Henderson, S; Williams, I; Wilder, N; Tyrer, M; ... others, ; + view all (2003) PATHOGENESIS AND IMMUNITY-Kaposi’s Sarcoma-Associated Herpesvirus Cytatoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes. Journal of Virology , 77 (7) pp. 4306-4314.

Stebbing, J; Bourloulia, D; Johnson, M; Henderson, S; Gotch, F; Boshoff, C; (2003) KSHV specific CTLs target Darwinian positively selected autologous epitopes within ORF-K1. J Virol

Strauss, SJ; Marples, M; Napier, MP; Meyer, T; Boxall, J; Rustin, GJS; (2003) A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. Br J Cancer , 89 (10) pp. 1901-1905. 10.1038/sj.bjc.6601414.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; Kilby, A; ... Whelan, JS; + view all (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. Journal of Clinical Oncology , 21 (15) pp. 2974-2981. 10.1200/JCO.2003.04.106.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; Kilby, A; ... Whelan, JS; + view all (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. J CLIN ONCOL , 21 (15) 2974 - 2981. 10.1200/JCO.2003.04.106.

Stubbs, M; Khan, K; Savage, K; McStay, M; Dhillon, AP; Caplin, ME; (2003) CCK2 receptor as a therapeutic target for neuroendocrine tumours. In: (pp. 108-).

Stubbs, M; Khan, K; Savage, K; McStay, M; Dhillon, AP; Caplin, ME; (2003) CCK2 receptor as a therapeutic target for neuroendocrine tumours. ENDOCR-RELAT CANCER , 10 (4) 505 - 505.

Su'etsugu, M; Emoto, A; Fujimitsu, K; Keyamura, K; Katayama, T; (2003) Transcriptional control for initiation of chromosomal replication in Escherichia coli: fluctuation of the level of origin transcription ensures timely initiation. GENES TO CELLS , 8 (9) pp. 731-745. 10.1046/j.1365-2443.2003.00671.x.

T

The, T; (2003) Conditions: Lung Cancer.

Thirlwell, C; Brock, CS; (2003) Emergencies in oncology. CLIN MED , 3 (4) 306 - 310.

Tipping, AJ; Baluch, S; Mahon, FX; Veach, DR; Bornmann, WG; Clarkson, BD; Goldman, JM; (2003) Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate. In: BLOOD. (pp. 858A - 858A). AMER SOC HEMATOLOGY

Tischkowitz, M; Pharoah, P; Mackay, J; (2003) Genetic Susceptibility to Ovarian cancer; Molecular and Clinical Aspects. In: Gore, M and Kehoe, S and Ledermann, J and Miles, A, (eds.) Key Advances in the Effective Management of Ovarian Cancer. Aesculapius: London.

Treurnicht, K; Danta, M; Dhillon, AP; (2003) Thyroid transcription factor (TTF)-1 immunostaining in hepatocellular carcinoma. In: JOURNAL OF PATHOLOGY. (pp. 21A - 21A). JOHN WILEY & SONS LTD

Tucker, E; Buda, A; Janghra, N; Baker, J; Coad, J; Moorghan, M; Havler, M; ... Pignatelli, M; + view all (2003) Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis (vol 62, pg 230, 2003). PROCEEDINGS OF THE NUTRITION SOCIETY , 62 (2) p. 571. 10.1079/PNS2003292.

Turner, NC; Hochhauser, D; (2003) New Targets in oesophagogastric cancer. In: Key Advances in Clinical Practice: The Effective Management of Oesophagogastric Cancer. Aesculapius Press

U

UCL, PA; (2003) Scans help spot lung cancer early. 29-.

V

Vassileva, VT; (2003) Analysis of Genetic Targets Contributing to Mutator Phenotype of Endometrial Cancer. Masters thesis , University of Toronto.

Venables, K; Winfield, EA; Aird, EGA; Hoskin, PJ; (2003) Three-dimensional distribution of radiation within the breast: An intercomparison of departments participating in the start trial of breast radiotherapy fractionation. International Journal of Radiation Oncology Biology Physics , 55 (1) pp. 271-279.

Viviani, B; Bartesaghi, S; Gardoni, F; Vezzani, A; Behrens, MM; Bartfai, T; Binaglia, M; ... Marinovich, M; + view all (2003) Interleukin-1 beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the SRC family of kinases. In: GLIA. (pp. 57 - 57). WILEY-LISS

Viviani, B; Bartesaghi, S; Vezzani, A; Binaglia, M; Galli, CL; Marinovich, M; (2003) Interleukin-1 beta enhances NMDA receptor-mediated [Ca2+](1) increase in primary rat hippocampal neurons: Role in neurotoxicity. In: TOXICOLOGICAL SCIENCES. (pp. 265 - 265). OXFORD UNIV PRESS

W

Wald, N.J.; Huttly, W.J.; Hackshaw, A.K.; (2003) Antenatal screening for Down's syndrome with the quadruple test. The Lancet , 361 (9360) pp. 835-836. 10.1016/S0140-6736(03)12680-3.

Ward, LK; Clarke, R; Hackshaw, AK; (2003) Do food-plant preferences of modern families of phytophagous insects and mites reflect past evolution with plants? Biological Journal of the Linnean Society , 78 pp. 51-83.

Watts, MJ; Ings, SJ; Balsa, C; Ahmed, F; Scott, M; Richardson, K; Linch, DC; (2003) Storage of PBSC in liquid phase for 16 hours leads to occult progenitor cell damage only fully apparent after freeze thawing. In: BLOOD. (pp. 40A - 40A). AMER SOC HEMATOLOGY

Wells, G; Gale, T; Hardy, A; Hamaguchi, A; Hartley, JA; Wilkinson, GP; Loadman, P; ... Thurston, DE; + view all (2003) Pyrrolobenzodiazepine-polyamide libraries:synthesis and DNA binding selectivity. Proceeding of the American Association for Cancer Research. In: (pp. 452-).

Wells, P; Aboagye, E; Gunn, RN; Osman, S; Boddy, AV; Taylor, GA; Rafi, I; ... Newell, DR; + view all (2003) 2-[C-11]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337. J NATL CANCER I , 95 (9) 675 - 682.

Westbury, CB; Harrington, KJ; Rhys-Evans, P; Archer, DJ; Searle, AE; Henk, JM; Black, CM; (2003) Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. POSTGRAD MED J , 79 (929) 176 - 177.

Whelan, J; (2003) Studies on cellular sensitivity and resistance to cytosine arabinoside. UNSPECIFIED thesis , UNSPECIFIED.

Whelan, JS; (2003) Working with Adolescents. ESMO Summer Educational Conference, Edinburgh June 2003. In: (pp. 42-).

Whelan, JS; McTiernan, A; (2003) Survival after recurrence of Ewing’s tumour is improved by high dose chemotherapy and surgery. Results of a retrospective analysis of 116 patients. In:

Whelan, JS; O, SC; Stanway, S; Ng, S; (2003) How should glomerular filtration rates be measured in teenagers having chemotherapy? In:

Whiteway, A; Corbett, T; Anderson, R; Macdonald, I; Prentice, HG; (2003) Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. British Journal of Haematology , 120 (3) pp. 442-451.

Whiteway, A; Deru, W; Prentice, HG; Anderson, R; (2003) Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions. JOURNAL OF VIROLOGICAL METHODS , 114 (1) pp. 1-10. 10.1016/j.jviromet.2003.08.001.

Wilbourn, B; Harrison, P; Mackie, IJ; Liesner, R; Machin, SJ; (2003) Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism. British Journal of Haematology , 122 (4) pp. 651-661. 10.1046/j.1365-2141.2003.04461.x.

Wilkinson, GP; Loadman, P; Taylor, J; Jenkins, TC; Swaine, D; Double, JA; Spanswick, VJ; ... Thurston, DE; + view all (2003) Pharmacokinetic and intracellular pharmacological characteristics of the novel pyrrolobenzodiazepine (PBD) dimmer SJG-136. In: (pp. 1634-).

Williams, E; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Preliminary data from the Medical Devices Agency (MDA) study of the CoaguCheck S in a patient self-testing environment. Br J Haematol , 121 (Suppl 1) p. 7.

Winfield, EA; Deighton, A; Venables, K; Hoskin, PJ; Aird, EGA; (2003) Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer. British Journal of Radiology , 76 (904) pp. 254-259.

Wong, WL; Saunders, M; (2003) The impact of FDG PET on the management of occult primary head and neck tumours. Clinical Oncology , 15 (8) pp. 461-466.

Y

Yarranton, H; Cohen, H; Machin, SJ; (2003) Venous thromboembolism (VTE) associated withthe management of acute thrombotic thrombocytopenic purpura (TTP). In: (Proceedings) International society of thrombosis and haemostasis.

Yarranton, H; Cohen, H; Pavord, SR; Benjamin, S; Hagger, D; Machin, SJ; (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 121 (5) 778 - 785.

Yarranton, H; Lawrie, AS; Mackie, IJ; Machin, SJ; Pinkoski, L; Corash, L; (2003) Coagulation factor levels in cryosupernatant treated with amotosalen hydrochloride (S-59) and UVA light - a suitable plasma replacement in thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 817A - 817A). AMER SOC HEMATOLOGY

This list was generated on Sun Apr 15 02:51:06 2018 BST.